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Background:  Recent increasing prevalence of heart failure (HF) patients leads to an increasing burden to the health care system. Consequently, 
there is a need for innovative strategies to reduce HF hospitalizations.
Methods:  We performed a multicentre randomized controlled trial to test the hypothesis that telemonitoring in patients with HF, by means of the 
Health Buddy® system (HB), will reduce HF hospitalizations and number of contacts with caregivers as compared to care as usual (CAU) during 1 
year follow-up, from October 1, 2007, through December 31, 2008.
Results:  Among 382 patients - 197 in the HB and 185 in the CAU-group - 226 (59%) were male, mean age was 71.5 (SD 11.2), 45.5% being 
≥75years of age; 57% of the patients were in NYHA HF class 2, 40% in class 3 and 3% in class 4. Both study groups were similar for demographic 
and clinical characteristics. During follow-up, HF admissions occurred in 18 (9.1%) patients in the HB-group compared to 25 (13.5%) in the CAU-
group (unadjusted OR=0.64, 95% CI 0.34-1.22, p=0.176). HF re-admissions occurred in 5 (2.7%) patients in the HB- compared to 11 (6.4%) in the 
CAU-group (unadjusted OR=0.41, CI 0.14-1.20, p=0.089). Adjusted for baseline urea, heart rate, systolic blood pressure, atrial fibrillation and having 
a pacemaker, the Cox regression effect (CRE) for the HB-group compared to CAU-group became statistically significant (X 2 L= 10.96, p=0.001) 
in patients with a history of HF up to 18 months. If HF history was more than 18 months no effect was seen (CRE=0.36, CI 0.09-1.37, p=0.122), 
neither in single admissions, independently of HF-duration (0.58, CI 0.26-1.28, p=0.177). A total of 18 (9.1%) patients deceased during follow-up 
in the HB-group and 12 (6.5%) in the CAU-group (p=0.334). Adjusted for NYHA, baseline urea and age, the CRE for mortality was 0.913, CI 0.42-
1.98, p=0.818. The mean rate of outpatient contacts with the HF-nurse for the HB- and CAU-group was 1.36 (SD 1.68) and 1.74 (SD 1.48) (M-W 
p<0.001).
Conclusions:  Telemonitoring using the HB reduced hospital admissions for HF significantly. This reduction was concentrated in re-admissions of 
patients with a HF history up to 18 months. Moreover telemonitoring reduced outpatients contacts with caregivers.
